UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 577

Sortiert nach

Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial

Annals of oncology, 2020-06, Vol.31 (6), p.798-806

2020

Link zum Volltext

Verfügbarkeit prüfen

Radioimmunotherapy for the treatment of head and neck cancer

The lancet oncology, 2019-08, Vol.20 (8), p.e404-e416

2019

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive genomic profiling of salivary mucoepidermoid carcinomas reveals frequent BAP1, PIK3CA, and other actionable genomic alterations

Annals of oncology, 2017-04, Vol.28 (4), p.748-753

2017

Link zum Volltext

Verfügbarkeit prüfen

Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)

Annals of oncology, 2019-02, Vol.30 (2), p.161-165

2019

Link zum Volltext

Verfügbarkeit prüfen

Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study

PloS one, 2015-11, Vol.10 (11), p.e0140845-e0140845

2015

Link zum Volltext

Verfügbarkeit prüfen

Late presentation of HIV infection: a consensus definition

HIV medicine, 2011-01, Vol.12 (1), p.61-64

2011

Link zum Volltext

Verfügbarkeit prüfen

Increased integrated testing for HIV, hepatitis C and sexually transmitted infections in health care facilities: results from the INTEGRATE Joint Action pilots in Lithuania, Romania and Spain

BMC infectious diseases, 2021-09, Vol.21 (Suppl 2), p.845-845, Article 845

2021

Link zum Volltext

Verfügbarkeit prüfen

HIV testing strategies outside of health care settings in the European Union (EU)/European Economic Area (EEA): a systematic review to inform European Centre for Disease Prevention and Control guidance

HIV medicine, 2020-03, Vol.21 (3), p.142-162

2020

Link zum Volltext

Verfügbarkeit prüfen

Measuring Diacylglycerol Kinase-θ Activity and Binding

Methods in enzymology, 2017, Vol.583, p.231-253

2017

Link zum Volltext

Verfügbarkeit prüfen

HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA): evidence from a systematic review

HIV medicine, 2020-03, Vol.21 (3), p.163-179

2020

Link zum Volltext

Verfügbarkeit prüfen

The EuroSIDA study: 25 years of scientific achievements

HIV medicine, 2020-02, Vol.21 (2), p.71-83

2020

Link zum Volltext

Verfügbarkeit prüfen

SP-0298: Phase I Results of PARPi (Olaparib) + RT + Cetuximab in LAHNSCC

Radiotherapy and oncology, 2016-04, Vol.119, p.S138-S139

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC

Annals of oncology, 2018-10, Vol.29, p.viii488-viii488

2018

Link zum Volltext

Verfügbarkeit prüfen

IMvoke010: Randomized phase III study of atezolizumab (atezo) as adjuvant monotherapy after definitive therapy of squamous cell carcinoma of the head and neck (SCCHN)

Annals of oncology, 2018-10, Vol.29, p.viii397-viii397

2018

Link zum Volltext

Verfügbarkeit prüfen

Does Age Matter? Survival Outcomes With the Addition of Concurrent Chemotherapy for Elderly Head and Neck Cancer Patients Undergoing Definitive Radiation Using the National Cancer Data Base

International journal of radiation oncology, biology, physics, 2016-03, Vol.94 (4), p.871-871

2016

Link zum Volltext

Verfügbarkeit prüfen

Induction Chemotherapy Predicts Cumulative Radiation Dose and Fails to Improve Survival in Advanced Head and Neck Cancer, a National Cancer Data Base Analysis

International journal of radiation oncology, biology, physics, 2016-03, Vol.94 (4), p.874-875

2016

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditions

HIV medicine, 2017-04, Vol.18 (4), p.300-304

2017

Link zum Volltext

Verfügbarkeit prüfen

Lymph Node-Positive (N1M0) Prostate Cancer: An Analysis of Prognostic and Predictive Factors for Men Treated With and Without Definitive External Beam Radiation Therapy in the United States Population

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S14-S14

2014

Link zum Volltext

Verfügbarkeit prüfen

Proton Beam Therapy Utilization and Disparity in the United States for Treatment of Localized Prostate Cancer: A Study of the National Cancer Data Base

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E244-E245

2016

Link zum Volltext

Verfügbarkeit prüfen

359 NEW INSIGHTS IN DNA REPAIR TARGETING AND RADIOTHERAPY IN HEAD AND NECK CANCER

Radiotherapy and oncology, 2012-03, Vol.102, p.S186-S187

2012

Link zum Volltext

Verfügbarkeit prüfen

A Multicenter Experience in Contralateral Submandibular Gland Sparing in Head and Neck Radiation Therapy: An Assessment of Feasibility and Safety

International journal of radiation oncology, biology, physics, 2014-02, Vol.88 (2), p.469-470

2014

Link zum Volltext

Verfügbarkeit prüfen

The case for indicator condition‐guided HIV screening

HIV medicine, 2013-08, Vol.14 (7), p.445-448

2013

Link zum Volltext

Verfügbarkeit prüfen

Dose Painting to Treat Single Lobe Prostate Cancer Using Targeted External Beam Radiation Therapy - Is It Feasible?

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S945-S945

2014

Link zum Volltext

Verfügbarkeit prüfen

Comprehensive genomic profiling of salivary mucoepidermoid carcinomas reveals frequentBAP1,PIK3CA, and other actionable genomic alterations

Annals of oncology, 2017-04, Vol.28 (4), p.748-753

2017

Link zum Volltext

Verfügbarkeit prüfen

Disparities in Disease Presentation for Breast, Prostate, Colorectal, and Cervical Cancer According to Insurance Status: Does Insurance Status Predict for Worse Disease Presentation in the Four Screenable Cancers?

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E371-E371

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 577

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(551)
Mit Volltextzugriff
(526)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(570)
Japanisch
(57)
Russisch
(3)
Dänisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(323)
Life Sciences & Biomedicine
(294)
Humans
(241)
Male
(151)
Female
(126)
Middle Aged
(119)
Adult
(104)
Oncology
(102)
Aged
(93)
Biological And Medical Sciences
(79)
Animals
(77)
Hematology, Oncology And Palliative Medicine
(63)
Radiology
(52)
Medical Sciences
(51)
Infectious Diseases
(50)
Hiv
(47)
Human Immunodeficiency Virus
(40)
Aged, 80 And Over
(33)
Medicin Och Hälsovetenskap
(32)
Fundamental And Applied Biological Sciences. Psychology
(31)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial

Radioimmunotherapy for the treatment of head and neck cancer

Comprehensive genomic profiling of salivary mucoepidermoid carcinomas reveals frequent BAP1, PIK3CA, and other actionable genomic alterations

Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)

Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study

Late presentation of HIV infection: a consensus definition

Increased integrated testing for HIV, hepatitis C and sexually transmitted infections in health care facilities: results from the INTEGRATE Joint Action pilots in Lithuania, Romania and Spain

HIV testing strategies outside of health care settings in the European Union (EU)/European Economic Area (EEA): a systematic review to inform European Centre for Disease Prevention and Control guidance

Measuring Diacylglycerol Kinase-θ Activity and Binding

HIV testing strategies employed in health care settings in the European Union/European Economic Area (EU/EEA): evidence from a systematic review

The EuroSIDA study: 25 years of scientific achievements

SP-0298: Phase I Results of PARPi (Olaparib) + RT + Cetuximab in LAHNSCC

Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC

IMvoke010: Randomized phase III study of atezolizumab (atezo) as adjuvant monotherapy after definitive therapy of squamous cell carcinoma of the head and neck (SCCHN)

Does Age Matter? Survival Outcomes With the Addition of Concurrent Chemotherapy for Elderly Head and Neck Cancer Patients Undergoing Definitive Radiation Using the National Cancer Data Base

Induction Chemotherapy Predicts Cumulative Radiation Dose and Fails to Improve Survival in Advanced Head and Neck Cancer, a National Cancer Data Base Analysis

Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditions

Lymph Node-Positive (N1M0) Prostate Cancer: An Analysis of Prognostic and Predictive Factors for Men Treated With and Without Definitive External Beam Radiation Therapy in the United States Population

Proton Beam Therapy Utilization and Disparity in the United States for Treatment of Localized Prostate Cancer: A Study of the National Cancer Data Base

359 NEW INSIGHTS IN DNA REPAIR TARGETING AND RADIOTHERAPY IN HEAD AND NECK CANCER

A Multicenter Experience in Contralateral Submandibular Gland Sparing in Head and Neck Radiation Therapy: An Assessment of Feasibility and Safety

The case for indicator condition‐guided HIV screening

Dose Painting to Treat Single Lobe Prostate Cancer Using Targeted External Beam Radiation Therapy - Is It Feasible?

Comprehensive genomic profiling of salivary mucoepidermoid carcinomas reveals frequentBAP1,PIK3CA, and other actionable genomic alterations

Disparities in Disease Presentation for Breast, Prostate, Colorectal, and Cervical Cancer According to Insurance Status: Does Insurance Status Predict for Worse Disease Presentation in the Four Screenable Cancers?

Suchergebnisse filtern